New appointment

Article

Lions Clubs International Foundation (LCIF) has appointed Dr Wing-Kun Tam to the global advisory council of the Paediatric Cataract Initiative

Lions Clubs International Foundation (LCIF) has appointed Dr Wing-Kun Tam to the global advisory council of the Paediatric Cataract Initiative (www.PediatricCataract.org).

The newly founded initiative is using the resources of the Bausch + Lomb Early Vision Institute and LCIF to identify, fund and promote innovative methods of overcoming paediatric.

Dr Tam was recently elected as the first vice president of Lions Clubs International at its International Convention in Sydney, Australia. He will become president of Lions Clubs International in June 2011. /p>

Dr Tam was instrumental in launching the SightFirst China Action programme in 1990 between LCIF’s SightFirst Programme and the People’s Republic of China. This partnership paired Lions Clubs blindness prevention mobilization efforts with financial support for SightFirst China Action, and was matched by $200 million from the Chinese government. Since the programme’s launch, SightFirst China Action has restored sight by providing cataract surgeries to more than five million people in China and strengthening the eye care infrastructure by creating secondary eye care units at hospitals in 200 counties with under developed eye care within China’s provinces and in Tibet.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.